These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26894429)

  • 1. Depot-Specific Changes in Fat Metabolism with Aging in a Type 2 Diabetic Animal Model.
    Park SE; Park CY; Choi JM; Chang E; Rhee EJ; Lee WY; Oh KW; Park SW; Kang ES; Lee HC; Cha BS
    PLoS One; 2016; 11(2):e0148141. PubMed ID: 26894429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of the depot specificity of peroxisome proliferator-activated receptor gamma action on adipose tissue metabolism.
    Laplante M; Festuccia WT; Soucy G; Gélinas Y; Lalonde J; Berger JP; Deshaies Y
    Diabetes; 2006 Oct; 55(10):2771-8. PubMed ID: 17003342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor γ activation favours selective subcutaneous lipid deposition by coordinately regulating lipoprotein lipase modulators, fatty acid transporters and lipogenic enzymes.
    Blanchard PG; Turcotte V; Côté M; Gélinas Y; Nilsson S; Olivecrona G; Deshaies Y; Festuccia WT
    Acta Physiol (Oxf); 2016 Jul; 217(3):227-39. PubMed ID: 26918671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model.
    Kim HJ; Jung TW; Kang ES; Kim DJ; Ahn CW; Lee KW; Lee HC; Cha BS
    Metabolism; 2007 May; 56(5):676-85. PubMed ID: 17445544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depot-specific effects of the PPARgamma agonist rosiglitazone on adipose tissue glucose uptake and metabolism.
    Festuccia WT; Blanchard PG; Turcotte V; Laplante M; Sariahmetoglu M; Brindley DN; Deshaies Y
    J Lipid Res; 2009 Jun; 50(6):1185-94. PubMed ID: 19201733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia.
    Berthiaume M; Laplante M; Tchernof A; Deshaies Y
    Int J Obes (Lond); 2007 Nov; 31(11):1660-70. PubMed ID: 17579631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional differences in the expression of genes involved in lipid metabolism in adipose tissue in response to short- and medium-term fasting and refeeding.
    Palou M; Sánchez J; Priego T; Rodríguez AM; Picó C; Palou A
    J Nutr Biochem; 2010 Jan; 21(1):23-33. PubMed ID: 19157823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The key role of a glucagon-like peptide-1 receptor agonist in body fat redistribution.
    Zhao L; Zhu C; Lu M; Chen C; Nie X; Abudukerimu B; Zhang K; Ning Z; Chen Y; Cheng J; Xia F; Wang N; Jensen MD; Lu Y
    J Endocrinol; 2019 Feb; 240(2):271-286. PubMed ID: 30530905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major involvement of mTOR in the PPARγ-induced stimulation of adipose tissue lipid uptake and fat accretion.
    Blanchard PG; Festuccia WT; Houde VP; St-Pierre P; Brûlé S; Turcotte V; Côté M; Bellmann K; Marette A; Deshaies Y
    J Lipid Res; 2012 Jun; 53(6):1117-25. PubMed ID: 22467681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression patterns in visceral and subcutaneous adipose depots in rats are linked to their morphologic features.
    Palou M; Priego T; Sánchez J; Rodríguez AM; Palou A; Picó C
    Cell Physiol Biochem; 2009; 24(5-6):547-56. PubMed ID: 19910695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance.
    Kabir M; Catalano KJ; Ananthnarayan S; Kim SP; Van Citters GW; Dea MK; Bergman RN
    Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E454-61. PubMed ID: 15522994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
    Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
    Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation- and lipid metabolism-related gene network expression in visceral and subcutaneous adipose depots of Holstein cows.
    Ji P; Drackley JK; Khan MJ; Loor JJ
    J Dairy Sci; 2014; 97(6):3441-8. PubMed ID: 24704230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
    Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
    Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GQ-16, a TZD-Derived Partial PPARγ Agonist, Induces the Expression of Thermogenesis-Related Genes in Brown Fat and Visceral White Fat and Decreases Visceral Adiposity in Obese and Hyperglycemic Mice.
    Coelho MS; de Lima CL; Royer C; Silva JB; Oliveira FC; Christ CG; Pereira SA; Bao SN; Lima MC; Pitta MG; Pitta IR; Neves FA; Amato AA
    PLoS One; 2016; 11(5):e0154310. PubMed ID: 27138164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARgamma agonism increases rat adipose tissue lipolysis, expression of glyceride lipases, and the response of lipolysis to hormonal control.
    Festuccia WT; Laplante M; Berthiaume M; Gélinas Y; Deshaies Y
    Diabetologia; 2006 Oct; 49(10):2427-36. PubMed ID: 16906479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone differentially regulates targets of lipid and glucose metabolism in liver, muscle and adipose tissues of the testicular feminised mouse.
    Kelly DM; Akhtar S; Sellers DJ; Muraleedharan V; Channer KS; Jones TH
    Endocrine; 2016 Nov; 54(2):504-515. PubMed ID: 27488580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related changes in fatty acids from different adipose depots in rat and their association with adiposity and insulin.
    de Heredia FP; Larque E; Portillo MP; Canteras M; Zamora S; Garaulet M
    Nutrition; 2008 Oct; 24(10):1013-22. PubMed ID: 18562171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic low-dose glucocorticoid treatment increases subcutaneous abdominal fat, but not visceral fat, of male Wistar rats.
    Nunes PP; Andreotti S; de Fátima Silva F; Sertié RAL; Caminhotto RO; Komino ACM; Reis GB; Lima FB
    Life Sci; 2017 Dec; 190():29-35. PubMed ID: 28958474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
    Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.